Form Type: 4

Accession Number:	0001193805-21-000864
Date:	2021-06-10
Issuer:	IMMUNIC, INC. (IMUX)
Original Submission Date:

Reporting Person:

VAN DEN BOSSCHE JAN
1200 AVENUE OF THE AMERICAS, SUITE 200
NEW YORK, NY 10036

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of Security	Transaction Date	2a. Deemed Execution Date	Transaction Code	Shares	Acquired or Disposed	Price per share	5. Amount of Securities Beneficially Owned Following Reported Transaction	6. Ownership Form Direct or Indirect	Nature of Indirect Ownership

Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security	Conversion or Exercise Price of Derivative Security	Transaction Date	Deemed Execution Date	Transaction Code	Number of Derivative Securities Acquired (A) or Disposed of (D)	Date Exercisable	Expiration Date	Title and Amount of Securities Underlying Derivative Security	Price of Derivative Security	Number of derivative Securities Beneficially Owned Following Reported Transaction(s)	Ownership Form: Direct (D) or Indirect (I)	Nature of Indirect Beneficial Ownership
STOCK OPTION	14.77	2021-06-10	deemed execution date	A	10,000 (a)		2031-06-10	common stock 10,000	$14.77	10,000	direct

Footnotes
ID	footnote
f1	the option vests in monthly increments over a period of one year from the grant date.

Elevate your investments